340B Hospital Community Benefit Analysis

In 2017 alone, 340B Tax-exempt Hospitals Provided More Than
$64 Billion in Total Benefits to Their Communities

 

Improving the health of their communities is at the heart of every hospital’s mission.

Tax-exempt hospitals are required to publicly report on the ways in which they improve the health of the communities they serve yearly through the IRS Form 990 Schedule H, which is publicly available. In 2017, the most recent year for which this information is available, tax-exempt hospitals participating in the 340B drug savings program provided $64.3B in total benefits to their communities. View details under key resources.

340B Hospital Community Benefit Analysis Report Cover

Related Resources

Webinar Recordings
Member
Your browser does not support the video tag.
Action Alert
Member
In response to recent actions taken by a number of drug companies to limit the distribution of certain 340B drugs to hospitals and health systems, Reps. Diana…
Letter/Comment
Public
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our…
Letter/Comment
Public
On behalf of the nation’s 340B hospitals, AHA, others urge the Department of Health and Human Services (HHS) to protect vulnerable communities from actions…
Letter/Comment
Public
AHA expresses profound concern about actions Eli Lilly and Company is taking to collect data intended to limit the distribution of certain 340B drugs to…
Letter/Comment
Public
AHA expresses profound concern about actions AztraZeneca is taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and…